Company Overview and News
Chicago, IL – Dec 20, 2017 - Stocks in this week’s article include: BioTime Inc. (BTX - Free Report) , Ritter Pharmaceuticals Inc. (RTTR - Free Report) , Organovo Holdings Inc. (ONVO - Free Report) , American Superconductor Corp. (AMSC - Free Report) and Stratasys Ltd. (SSYS - Free Report) . (116-0)
Chicago, IL – Dec 5, 2017 - Stocks in this week’s article include: BioTime Inc. (BTX - Free Report) , Ritter Pharmaceuticals Inc. (RTTR - Free Report) , Organovo Holdings Inc. (ONVO - Free Report) , Signal Genetics Inc. (MGEN - Free Report) and Stratasys Ltd. (SSYS - Free Report) . (200-2)
Generally, investors love stocks with a low price-to-earnings (P/E) ratio. The general perception is that the lower the P/E, the higher will be the value of the stock. The simple logic that a stock’s current market price does not justify (is not equivalent to) its higher earnings and therefore has room to run is behind investors’ inclination toward low P/E stocks. (121-0)
Chicago, IL – November 20, 2017 – Zacks Equity Research highlights Garmin Ltd (GRMN - Free Report) as the Bull of the Day and Fabrinet (FN - Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Salesfore.com (CRM - Free Report) , Hewlett Packard Enterprise (HPE - Free Report) and Deere & Company (DE - Free Report) . (96-2)
Chicago, IL – November 20, 2017 - Stocks in this week’s article Michael Kors Holdings Limited (KORS - Free Report) , Tyson Foods, Inc. (TSN - Free Report) , Sprouts Farmers Market, Inc. (SFM - Free Report) , Triple-S Management Corporation (GTS - Free Report) and Rayonier Inc. (RYN - Free Report) (747-6)
Chicago, IL – November 20, 2017 - Stocks in this week’s article Fortuna Silver Mines Inc. (FSM - Free Report) , Ritter Pharmaceuticals Inc. (RTTR - Free Report) , Organovo Holdings, Inc. (ONVO - Free Report) , Western Digital Corporation (WDC - Free Report) and Willdan Group Inc. (WLDN - Free Report) (89-2)
Good afternoon, and welcome to the Organovo Holdings Fiscal Second Quarter 2018 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded. (46-3)
October 10, 2017: Here are four stocks trading with heavy volume among 40 equities making new 52-week lows in Tuesday’s session. On the NYSE, advancers led decliners by about 2 to 1 and on the Nasdaq advancers led decliners by about the same ratio. (186-2)
SAN DIEGO, Oct. 04, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today reported preliminary unaudited total revenue for the fiscal second quarter of 2018. The Company expects to release full fiscal second-quarter financial results on November 9, 2017. The Company also announced a restructuring plan to improve operational efficiency. (61-1)
3D printing is another technological milestone in the history of printing. It became a reality in the early 1980s and the biomedical industry started using it in the early 2000s. The process has gone from creating tiny sheets of tissue to entire 3D organs nowadays. 3D printers are not the very last invention though, as they were followed by Solid Ink printing and Digital printing. (46-1)
A year ago, an 11-year-old girl named London Secor had surgery at the Mayo Clinic to remove a rare tumor located in her pelvis. In the past, surgeons would have considered amputating one of Ms. Secor’s legs, given that the tumor had spread to the bone and nerves of her sacrum and was encroaching on her hip socket. (2-6)
CORAL GABLES, FL / ACCESSWIRE / August 10, 2017 / Overall markets continued to dip on Thursday amid increasing tensions with North Korea. This included a rise in the fear index. Traditionally speaking the markets tend to dip as back-to-school season grows near but also factoring in these additional outside, global influencers, it has been a two-day downtrend. But even in spite of these events, there are several biotech stocks that have gone against the grain this month and are seeing bullish trends on Thursday, August 10. (0-1)
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.
Good afternoon, and welcome to the Organovo Fiscal First Quarter 2018 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded.
Stock Research Report
Organovo Holdings, Inc. is an early commercial stage company focused on developing and commercializing functional three-dimensional (“3D”) human tissues. Using its proprietary technologies and expertise in bioprinting, Organovo Holdings is building functional 3D human tissues that mimic key aspects of native biology, and can be used in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or diseased tissues and organs. Organovo Holdings is utilizing its proprietary bioprinting platform to create human tissue constructs in 3D that mimic native human tissue composition, architecture, and function. Organovo Holdings is leveraging its unique tissue models to improve the current industry standard cell-based and animal model testing approaches, and the company believe its foundational approach provides it with the opportunity to fill many critical gaps in commercially available preclinical human tissue models as well as in tissue trans...
2017-12-11 - Wilton
2017-12-11 - Wilton
2017-12-03 - Wilton
2017-11-27 - Wilton